{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T03:53:11Z","timestamp":1780545191585,"version":"3.54.1"},"reference-count":45,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2023,11,14]],"date-time":"2023-11-14T00:00:00Z","timestamp":1699920000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Association des Scl\u00e9rodermiques de France Young Researcher Program"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>To estimate the association between SSc clinical phenotypes and quantitative occupational exposure to crystalline silica, chlorinated solvents, trichloroethylene and pesticides using job-exposure matrices.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>In the VISS-EXPOSITION transversal study, data on declarative occupational exposure to crystalline silica, solvents and pesticides were retrieved. In parallel, the lifetime occupational history was evaluated using a questionnaire and cursus laboris for SSc patients followed at Bordeaux University Hospital (France). Using job-exposure matrices, we assessed patients\u2019 occupational exposure in relation to relevant clinical phenotypic forms of the disease.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Toxic exposure to crystalline silica and pesticides is underestimated by patients. Non-biased job-exposure matrices retrieved more exposed patients than the declarative assessment (10.1% of patients by job-exposure matrices vs 6.3% by declaration for crystalline silica and 25.9% vs 12.2% for pesticides). Patients overestimate their solvent exposure (7.9% for chlorinated solvents and 4.8% for trichlorethylene assessed by job-exposure matrices and 24.4% declarative exposure to solvents at large). Clinical form evaluation revealed a non-significant trend toward an increased risk of crystalline silica occupational exposure in the pulmonary fibrotic group of SSc patients [odds ratio (OR) 3.12 (95% CI 0.80, 12.15)]. We also observed a non-significant trend toward an elevated OR ([2.89 (95% CI 0.93, 8.95)] for chlorinated solvent occupational exposure and the vascular phenotype of SSc. Of note, pesticide occupational exposure evaluation represents one of the largest to date in SSc patients.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>This study emphasizes that many exposed SSc patients are unaware of their occupational exposure. Job-exposure matrices allow better exposure screening for SSc secondary prevention and occupational exposure compensation.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Clinical trial registration<\/jats:title>\n                  <jats:p>clinicaltrials.gov (https:\/\/www.clinicaltrials.gov), NCT03543956<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/kead602","type":"journal-article","created":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T22:29:18Z","timestamp":1699914558000},"page":"3397-3406","source":"Crossref","is-referenced-by-count":6,"title":["Occupational quantitative exposure to crystalline silica, solvents and pesticides and risk of clinical forms of systemic sclerosis"],"prefix":"10.1093","volume":"63","author":[{"given":"Ga\u00ebl","family":"Galli","sequence":"first","affiliation":[{"name":"University of Bordeaux, CNRS, ImmunoConcEpT, UMR 5164 , Bordeaux, Nouvelle-Aquitaine,","place":["France"]},{"name":"CHU de Bordeaux, FHU ACRONIM, Centre National de r\u00e9f\u00e9rence Des Maladies Autoimmunes et Syst\u00e9miques Rares Est\/Sud-Ouest (RESO) , Bordeaux, Nouvelle-Aquitaine,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"De Pous-Gerardin","sequence":"additional","affiliation":[{"name":"CHU de Bordeaux, Service Sant\u00e9 Travail Environnement , Bordeaux, Nouvelle-Aquitaine,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remi","family":"Hanguehard","sequence":"additional","affiliation":[{"name":"University of Bordeaux, INSERM, UMR 1219, Equipe EPICENE , Bordeaux, Nouvelle-Aquitaine,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florine","family":"Berthy","sequence":"additional","affiliation":[{"name":"University of Bordeaux, INSERM, UMR 1219, Equipe EPICENE , Bordeaux, Nouvelle-Aquitaine,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyril","family":"Le Moal","sequence":"additional","affiliation":[{"name":"Centre Hospitalier des Pays de Morlaix, Service de M\u00e9decine Interne , Morlaix, Bretagne,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Come","family":"Lourde","sequence":"additional","affiliation":[{"name":"14\u00e8bme Centre M\u00e9dical des Arm\u00e9es, 97\u00e8me Antenne M\u00e9dicale , Olivet, Centre Val de Loire,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Barnetche","sequence":"additional","affiliation":[{"name":"CHU de Bordeaux, FHU ACRONIM, Centre National de r\u00e9f\u00e9rence Des Maladies Autoimmunes et Syst\u00e9miques Rares Est\/Sud-Ouest (RESO) , Bordeaux, Nouvelle-Aquitaine,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Skopinski","sequence":"additional","affiliation":[{"name":"CHU de Bordeaux, FHU ACRONIM, Centre National de r\u00e9f\u00e9rence Des Maladies Autoimmunes et Syst\u00e9miques Rares Est\/Sud-Ouest (RESO) , Bordeaux, Nouvelle-Aquitaine,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecile","family":"Contin-Bordes","sequence":"additional","affiliation":[{"name":"University of Bordeaux, CNRS, ImmunoConcEpT, UMR 5164 , Bordeaux, Nouvelle-Aquitaine,","place":["France"]},{"name":"CHU de Bordeaux, FHU ACRONIM, Centre National de r\u00e9f\u00e9rence Des Maladies Autoimmunes et Syst\u00e9miques Rares Est\/Sud-Ouest (RESO) , Bordeaux, Nouvelle-Aquitaine,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fleur","family":"Delva","sequence":"additional","affiliation":[{"name":"University of Bordeaux, INSERM, UMR 1219, Equipe EPICENE , Bordeaux, Nouvelle-Aquitaine,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Carles","sequence":"additional","affiliation":[{"name":"CHU de Bordeaux, Service Sant\u00e9 Travail Environnement , Bordeaux, Nouvelle-Aquitaine,","place":["France"]},{"name":"University of Bordeaux, INSERM, UMR 1219, Equipe EPICENE , Bordeaux, Nouvelle-Aquitaine,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Elise","family":"Truchetet","sequence":"additional","affiliation":[{"name":"University of Bordeaux, CNRS, ImmunoConcEpT, UMR 5164 , Bordeaux, Nouvelle-Aquitaine,","place":["France"]},{"name":"CHU de Bordeaux, FHU ACRONIM, Centre National de r\u00e9f\u00e9rence Des Maladies Autoimmunes et Syst\u00e9miques Rares Est\/Sud-Ouest (RESO) , Bordeaux, Nouvelle-Aquitaine,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,11,14]]},"reference":[{"key":"2024121216442920100_kead602-B1","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/S0140-6736(17)30933-9","article-title":"Systemic sclerosis","volume":"390","author":"Denton","year":"2017","journal-title":"Lancet"},{"key":"2024121216442920100_kead602-B2","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/s12016-021-08889-8","article-title":"Current concepts on the pathogenesis of systemic sclerosis","volume":"64","author":"Truchetet","year":"2023","journal-title":"Clin Rev Allergy Immunol"},{"key":"2024121216442920100_kead602-B3","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s13075-019-1867-1","article-title":"Survival and prognosis factors in systemic sclerosis: data of a French multicenter cohort, systematic review, and meta-analysis of the literature","volume":"21","author":"Pokeerbux","year":"2019","journal-title":"Arthritis Res Ther"},{"key":"2024121216442920100_kead602-B4","doi-asserted-by":"crossref","first-page":"e151037","DOI":"10.1172\/jci.insight.151037","article-title":"PLG nanoparticles target fibroblasts and MARCO+ monocytes to reverse multiorgan fibrosis","volume":"7","author":"Xu","year":"2022","journal-title":"JCI Insight"},{"key":"2024121216442920100_kead602-B5","doi-asserted-by":"crossref","first-page":"532177","DOI":"10.3389\/fimmu.2020.532177","article-title":"Elevated circulatory levels of microparticles are associated to lung fibrosis and vasculopathy during systemic sclerosis","volume":"11","author":"Leleu","year":"2020","journal-title":"Front Immunol"},{"key":"2024121216442920100_kead602-B6","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1002\/art.42061","article-title":"Interleukin-1\u03b2-activated microvascular endothelial cells promote dc-sign-positive alternatively activated macrophages as a mechanism of skin fibrosis in systemic sclerosis","volume":"74","author":"Laurent","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"2024121216442920100_kead602-B7","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1136\/annrheumdis-2020-219748","article-title":"TGF\u03b2 promotes low IL10-producing ILC2 with profibrotic ability involved in skin fibrosis in systemic sclerosis","volume":"80","author":"Laurent","year":"2021","journal-title":"Ann Rheum Dis. d\u00e9c"},{"key":"2024121216442920100_kead602-B8","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3389\/fimmu.2020.00219","article-title":"Crystalline silica impairs efferocytosis abilities of human and mouse macrophages: implication for silica-associated systemic sclerosis","volume":"11","author":"Lescoat","year":"2020","journal-title":"Front Immunol"},{"key":"2024121216442920100_kead602-B9","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1038\/s41598-022-06581-1","article-title":"Tofacitinib and metformin reduce the dermal thickness and fibrosis in mouse model of systemic sclerosis","volume":"12","author":"Karatas","year":"2022","journal-title":"Sci Rep. d\u00e9c"},{"key":"2024121216442920100_kead602-B10","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1001\/jama.2014.6368","article-title":"Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: a randomized clinical trial","volume":"311","author":"van Laar","year":"2014","journal-title":"JAMA"},{"key":"2024121216442920100_kead602-B11","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/s41584-019-0184-z","article-title":"Emerging targets of disease-modifying therapy for systemic sclerosis","volume":"15","author":"Volkmann","year":"2019","journal-title":"Nat Rev Rheumatol. avr"},{"key":"2024121216442920100_kead602-B12","first-page":"152","article-title":"Sclerodermia, diffuse","volume":"33","author":"Bramwell","year":"1914","journal-title":"Trans Medico-Chir Soc Edinb"},{"key":"2024121216442920100_kead602-B13","first-page":"209","article-title":"Scleroderma in goldminers on the Witwatersrand with particular reference to pulmonary manifestations","volume":"3","author":"Erasmus","year":"1957","journal-title":"South Afr J Lab Clin Med Suid-Afr Tydskr Vir Lab- En Kliniekw"},{"key":"2024121216442920100_kead602-B14","first-page":"58","article-title":"Scleroderma caused by trichloroethylene effects","volume":"7","author":"Reinl","year":"1957","journal-title":"]. Zentralbl Arbeitsmed. mars"},{"key":"2024121216442920100_kead602-B15","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s10067-016-3533-1","article-title":"Occupational and environmental scleroderma. Systematic review and meta-analysis","volume":"36","author":"Rubio-Rivas","year":"2017","journal-title":"Clin Rheumatol"},{"key":"2024121216442920100_kead602-B16","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1007\/s10067-018-4045-y","article-title":"High prevalence of occupational exposure to solvents or silica in male systemic sclerosis patients: a Belgian cohort analysis","volume":"37","author":"De Decker","year":"2018","journal-title":"Clin Rheumatol"},{"key":"2024121216442920100_kead602-B17","doi-asserted-by":"crossref","first-page":"102727","DOI":"10.1016\/j.jaut.2021.102727","article-title":"Insights into the knowledge of complex diseases: environmental infectious\/toxic agents as potential etiopathogenetic factors of systemic sclerosis","volume":"124","author":"Ferri","year":"2021","journal-title":"J Autoimmun"},{"key":"2024121216442920100_kead602-B18","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1136\/oem.59.8.545","article-title":"Systemic sclerosis and occupational risk factors: a case-control study","volume":"59","author":"Diot","year":"2002","journal-title":"Occup Environ Med"},{"key":"2024121216442920100_kead602-B19","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1093\/rheumatology\/keac675","article-title":"Crystalline silica exposure in patients with rheumatoid arthritis and systemic sclerosis: a nationwide cross-sectional survey","volume":"62","author":"Cavalin","year":"2023","journal-title":"Rheumatology"},{"key":"2024121216442920100_kead602-B20","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jaut.2012.05.002","article-title":"Epidemiology of environmental exposures and human autoimmune diseases: findings from a National Institute of Environmental Health Sciences Expert Panel Workshop","volume":"39","author":"Miller","year":"2012","journal-title":"J Autoimmun"},{"key":"2024121216442920100_kead602-B21","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.berh.2017.09.005","article-title":"Understanding the role of environmental factors in the development of systemic lupus erythematosus","volume":"31","author":"Parks","year":"2017","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"2024121216442920100_kead602-B22","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1093\/annhyg\/mew007","article-title":"The Australian Work Exposures Study: prevalence of occupational exposure to respirable crystalline silica","volume":"60","author":"Si","year":"2016","journal-title":"Ann Occup Hyg"},{"key":"2024121216442920100_kead602-B23","doi-asserted-by":"crossref","first-page":"3900","DOI":"10.1093\/rheumatology\/keaa446","article-title":"Occupational silica exposure in an Australian systemic sclerosis cohort","volume":"59","author":"Patel","year":"2020","journal-title":"Rheumatology"},{"key":"2024121216442920100_kead602-B24","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s00420-009-0505-7","article-title":"Occupational silica exposure as a risk factor for scleroderma: a meta-analysis","volume":"83","author":"McCormic","year":"2010","journal-title":"Int Arch Occup Environ Health"},{"key":"2024121216442920100_kead602-B25","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.amjmed.2015.05.001","article-title":"Prospective risk of rheumatologic disease associated with occupational exposure in a cohort of male construction workers","volume":"128","author":"Blanc","year":"2015","journal-title":"Am J Med"},{"key":"2024121216442920100_kead602-B26","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1177\/1203475420957950","article-title":"Toward understanding of environmental risk factors in systemic sclerosis","volume":"25","author":"Ouchene","year":"2021","journal-title":"J Cutan Med Surg. mars"},{"key":"2024121216442920100_kead602-B27","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s00420-003-0462-5","article-title":"A case-control study of occupational exposures and systemic sclerosis","volume":"77","author":"Bovenzi","year":"2004","journal-title":"Int Arch Occup Environ Health"},{"key":"2024121216442920100_kead602-B28","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/PL00011216","article-title":"Exposure to solvents in female patients with scleroderma","volume":"21","author":"Czirj\u00e1k","year":"2002","journal-title":"Clin Rheumatol"},{"key":"2024121216442920100_kead602-B29","first-page":"2395","article-title":"Systemic sclerosis and occupational risk factors: role of solvents and cleaning products","volume":"31","author":"Ma\u00eetre","year":"2004","journal-title":"J Rheumatol"},{"key":"2024121216442920100_kead602-B30","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/ajim.1098","article-title":"Meta-analysis of systemic sclerosis and exposure to solvents","volume":"40","author":"Aryal","year":"2001","journal-title":"Am J Ind Med. 29 ao\u00fbt"},{"key":"2024121216442920100_kead602-B31","doi-asserted-by":"crossref","first-page":"e51506","DOI":"10.1371\/journal.pone.0051506","article-title":"Organic Solvents as Risk Factor for Autoimmune Diseases: a Systematic Review and Meta-Analysis","volume":"7","author":"Barrag\u00e1n-Mart\u00ednez","year":"2012","journal-title":"PLoS ONE"},{"key":"2024121216442920100_kead602-B32","first-page":"97","article-title":"Occupational exposure to solvents and gender-related risk of systemic sclerosis: a metaanalysis of case-control studies","volume":"34","author":"Kettaneh","year":"2007","journal-title":"J Rheumatol"},{"key":"2024121216442920100_kead602-B33","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1289\/ehp.11782","article-title":"Evidence of autoimmune-related effects of trichloroethylene exposure from studies in mice and humans","volume":"117","author":"Cooper","year":"2009","journal-title":"Environ Health Perspect"},{"key":"2024121216442920100_kead602-B34","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.rmed.2017.11.021","article-title":"Respiratory effects of trichloroethylene","volume":"134","author":"Dumas","year":"2018","journal-title":"Respir Med"},{"key":"2024121216442920100_kead602-B35","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.autrev.2013.10.002","article-title":"Prospective study to evaluate the association between systemic sclerosis and occupational exposure and review of the literature","volume":"13","author":"Marie","year":"2014","journal-title":"Autoimmun Rev"},{"key":"2024121216442920100_kead602-B36","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.autrev.2017.01.004","article-title":"Systemic sclerosis and exposure to heavy metals: a case control study of 100 patients and 300 controls","volume":"16","author":"Marie","year":"2017","journal-title":"Autoimmun Rev"},{"key":"2024121216442920100_kead602-B37","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jaad.2014.11.027","article-title":"Association of occupational exposure with features of systemic sclerosis","volume":"72","author":"Marie","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"2024121216442920100_kead602-B38","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.semarthrit.2015.06.004","article-title":"Clinical peculiarities of patients with scleroderma exposed to silica: a systematic review of the literature","volume":"45","author":"Freire","year":"2015","journal-title":"Semin Arthritis Rheum"},{"key":"2024121216442920100_kead602-B39","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.semarthrit.2020.08.014","article-title":"Association of silica exposure with chest HRCT and clinical characteristics in systemic sclerosis","volume":"50","author":"Ballerie","year":"2020","journal-title":"Semin Arthritis Rheum"},{"key":"2024121216442920100_kead602-B40","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s00296-015-3412-0","article-title":"Systemic sclerosis and silica exposure: a rare association in a large Brazilian cohort","volume":"36","author":"Rocha","year":"2016","journal-title":"Rheumatol Int"},{"key":"2024121216442920100_kead602-B41","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.chest.2021.11.009","article-title":"Independent Association Between Occupational Exposure and Decline of FVC in Systemic Sclerosis","volume":"161","author":"Thoreau","year":"2022","journal-title":"Chest"},{"key":"2024121216442920100_kead602-B42","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/art.38098","article-title":"2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European League Against Rheumatism Collaborative Initiative: ACR\/EULAR classification criteria for SSc","volume":"65","author":"van den Hoogen","year":"2013","journal-title":"Arthritis Rheum"},{"key":"2024121216442920100_kead602-B43","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/jes.2017.26","article-title":"Occupational exposure to pesticides: development of a job-exposure matrix for use in population-based studies (PESTIPOP)","volume":"28","author":"Carles","year":"2018","journal-title":"J Expo Sci Environ Epidemiol"},{"key":"2024121216442920100_kead602-B44","first-page":"865","article-title":"Matg\u00e9n\u00e9: a program to develop job-exposure matrices in the general population in France","volume":"55","author":"F\u00e9votte","year":"2011","journal-title":"Ann Occup Hyg"},{"key":"2024121216442920100_kead602-B45","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1751-0473-3-17","article-title":"Purposeful selection of variables in logistic regression","volume":"3","author":"Bursac","year":"2008","journal-title":"Source Code Biol Med"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/kead602\/54025429\/kead602.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/63\/12\/3397\/60903380\/kead602.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/63\/12\/3397\/60903380\/kead602.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T16:44:51Z","timestamp":1734021891000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/63\/12\/3397\/7420223"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,14]]},"references-count":45,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2023,11,14]]},"published-print":{"date-parts":[[2024,12,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/kead602","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,12]]},"published":{"date-parts":[[2023,11,14]]}}}